On Sept. 16, the Food and Drug Administration (FDA) permitted marketing of the Aera system, a device that uses a small balloon to treat persistent Eustachian tube dysfunction. Read more
Δ
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Notifications